SYSTEMATIC REVIEW
Published on 23 Sep 2022
Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials
doi 10.3389/fimmu.2022.999704
- 5,805 views
- 21 citations
6,578
Total downloads
18k
Total views and downloads
Select the journal/section where you want your idea to be submitted:
SYSTEMATIC REVIEW
Published on 23 Sep 2022
SYSTEMATIC REVIEW
Published on 24 May 2022
ORIGINAL RESEARCH
Published on 28 Mar 2022